CROSSJECT (EPA:ALCJ) | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Companies
CROSSJECT

PRESS RELEASE

published on 02/12/2025 at 07:30, 1 year 7 months ago

Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré
Crossject renouvelle Patrick Alexandre et Isabelle Liebschutz au sein d'un nouveau Directoire resserré pour se concentrer sur l'enregistrement du ZEPIZURE® auprès de la FDA et la commercialisation aux Etats-Unis

FDA Renouvellement Crossject ZEPIZURE® Directoire
BRIEF

published on 02/06/2025 at 07:35, 1 year 7 months ago

Modification des Obligations Convertibles par Crossject

Financement Obligations Convertibles Crossject ZEPIZURE Heights Capital
BRIEF

published on 02/06/2025 at 07:35, 1 year 7 months ago

Modification of Convertible Bonds by Crossject

Convertible Bonds Funding Crossject ZEPIZURE Heights Capital
PRESS RELEASE

published on 02/06/2025 at 07:30, 1 year 7 months ago

Réalisation des opérations annoncées en décembre 2024 relatives a la modification des obligations convertibles souscrites par une entité affiliée à Heights Capital Management, Inc. (« Heights ») et l’émission d’une seconde tranche ass
Crossject annonce la réalisation des opérations relatives à la modification des obligations convertibles souscrites par une entité affiliée à Heights Capital Management et l'émission d'une seconde tranche assimilable

Obligations Convertibles Émission Crossject Heights Capital Management Tranche Assimilable
PRESS RELEASE

published on 02/06/2025 at 07:30, 1 year 7 months ago

COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE
Crossject completes transactions announced in December 2024 related to amendment of convertible bonds subscribed by an entity affiliated to Heights Capital Management, Inc. Second assimilable tranche issued

Convertible Bonds Transaction Bond Issue Crossject Heights Capital Management
BRIEF

published on 01/20/2025 at 14:47, 1 year 7 months ago

Crossject : Mise à jour sur les droits de vote et actions au 31 décembre 2024

Droits De Vote Capital Social Actions 2024 Crossject
BRIEF

published on 01/20/2025 at 14:47, 1 year 7 months ago

Crossject: Update on voting rights and shares as of December 31, 2024

Share Capital Voting Rights Actions 2024 Crossject
PRESS RELEASE

published on 01/20/2025 at 14:42, 1 year 7 months ago

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
Crossject publie le nombre total de droits de vote et d'actions au 31 décembre 2024. La société développe des médicaments d'urgence

Droits De Vote Actions AMF Crossject Médicaments D'urgence
BRIEF

published on 12/31/2024 at 10:02, 1 year 8 months ago

Crossject : Détails sur le Capital Social et les Droits de Vote au 30 Novembre 2024

Droits De Vote Capital Social Actions AMF Crossject
BRIEF

published on 12/31/2024 at 10:02, 1 year 8 months ago

Crossject: Details on Share Capital and Voting Rights as of November 30, 2024

Share Capital Voting Rights Actions AMF Crossject

Accesswire

Published on 09/12/2026 at 02:35, 11 hours 34 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 9 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 4 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 44 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 9 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 6 hours 39 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 54 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 59 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 25 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 54 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 7 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE